Duncan, Vanessa M. S.Smith, DanielSimpson, LauraLovie, EmmaKatvars, LauraBerge, LeonRobertson, JenniferSmith, ShaneMunro, CarolMercer, DerryO'Neil, Deborah A.2021-09-252021-09-252021-07-16Duncan, V M S, Smith, D, Simpson, L, Lovie, E, Katvars, L, Berge, L, Robertson, J, Smith, S, Munro, C, Mercer, D & O'Neil, D A 2021, 'Preliminary Characterisation of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity', Antimicrobial Agents and Chemotherapy, vol. 65, no. 8, e02345-20. https://doi.org/10.1128/AAC.02345-200066-4804ORCID: /0000-0003-0761-1755/work/162729031https://hdl.handle.net/2164/17176FUNDING SOURCE The study was funded by NovaBiotics with support from The UK Governments’ Department of Health and Social Care, delivered by Innovate UK. Shane Smith and Carol Munro’s contribution to the project was funded by a Scottish Universities Life Sciences Alliance Bioskape grant award.181391816engSDG 3 - Good Health and Well-beingantifungal agentsantifungal resistanceantifungal therapyantimicrobial peptidesR MedicineOtherSupplementary InformationRJournal article10.1128/AAC.02345-20658